Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2006
A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancerEric J Small, Michael A Carducci, James M Burke, et al.
Plos Pathogens|March 26, 2026
Herpesvirus-encoded lncRNA targets host splicing by interacting with splicing factorsYuan Hong, Ritu Shekhar, Sarah McMahon, et al.
Cell Communication and Signaling : CCS|March 30, 2025
NEDD4 E3 ligase-catalyzed NAMPT ubiquitination and autophagy activation are essential for pyroptosis-independent NAMPT secretion in human monocytesMarisela Rodriguez, Haifei Xu, Annie Hernandez, et al.
The Journal of Urology|October 24, 2012
A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancerJames M Burke, Donald L Lamm, Maxwell V Meng, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
SARS-CoV-2 and MERS-CoV disrupt host protein synthesis via nsp1 with differential effects on the integrated stress responseNicholas A Parenti, Renee Cusic, David M Renner, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2026
SARS-CoV-2 and MERS-CoV disrupt host protein synthesis via nsp1 with differential effects on the integrated stress responseNicholas A Parenti, Renee Cusic, David M Renner, et al.
Mbio|December 10, 2025
Human alphacoronavirus replication and innate immune induction in airway culture systemsAlejandra Fausto, Clayton J Otter, Leonel Torres, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2024
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signalingClayton J Otter, Nicole Bracci, Nicholas A Parenti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2014
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patientsTimothy P Cripe, Minhtran C Ngo, James I Geller, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential assembly of RNP granules via activation of distinct dsRNA sensors by adenovirus mutantsRobert T Steinbock, Orlando B Scudero, Joseph M Dybas, et al.
Pageof 7